Browse Arkansas Code titles and sections
20-15-302. Testing of newborn infants.
Arkansas Code — all titles (historical 2020) · legal_authorities
20-15-302. Testing of newborn infants.
(a)(1)(A) All newborn infants shall be tested for phenylketonuria, hypothyroidism, galactosemia, cystic fibrosis, sickle-cell anemia, and spinal muscular atrophy.
(B) In addition, if reliable and efficient testing techniques are available, all newborn infants shall be tested for other genetic disorders by employing procedures approved by the State Board of Health.
(2)(A) Medicaid shall reimburse the hospital that performs the tests required under subdivision (a)(1) of this section for the cost of the tests.
(B) The reimbursement shall be in addition to the hospital's per diem payments for the newborn infant.
(b) All positive test results shall be sent immediately to the Department of Health.
(c)(1) The department shall establish and maintain a program of reviewing and following up on positive cases so that measures may be taken to prevent intellectual and other developmental disability or other permanent disabilities.
(2)(A) Information on newborn infants and their families compiled under this section may be used by the department and persons or public or private entities designated by the department.
(B) Information used under subdivision (c)(2)(A) of this section may not refer to or disclose the identity of any person.
(3) All materials, data, and information received by the department are confidential and are not subject to examination or disclosure as public information under the Freedom of Information Act of 1967, § 25-19-101 et seq.
(d)(1) The department shall conduct an intensive educational and training program among physicians, hospitals, public health nurses, and the public concerning the disorders covered under this section.
(2) The program shall include information concerning:
(A) The nature of t
Source: Arkansas Code — historical release 78 (November 6, 2020) · 20-15-302
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. A text match is a research starting point; applicability is not established.
Issuing source page ↗
Authority boundary: historical statutory source snapshot not current law.
Open the recorded source website ↗
Record provenance
Stable record: arkansas_code:legal_authorities:20-15-302
Source file: gov.ar.code.title.20.odt
Pages: Not recorded – Not recorded
Passage SHA-256: 688ef7e0c249614fffe0bfb6e7d343ea099d5e01398ba19e5167a227254698c3
Source location: content.xml paragraph 10787
Stored source content
20-15-302. Testing of newborn infants.
(a)(1)(A) All newborn infants shall be tested for phenylketonuria, hypothyroidism, galactosemia, cystic fibrosis, sickle-cell anemia, and spinal muscular atrophy.
(B) In addition, if reliable and efficient testing techniques are available, all newborn infants shall be tested for other genetic disorders by employing procedures approved by the State Board of Health.
(2)(A) Medicaid shall reimburse the hospital that performs the tests required under subdivision (a)(1) of this section for the cost of the tests.
(B) The reimbursement shall be in addition to the hospital's per diem payments for the newborn infant.
(b) All positive test results shall be sent immediately to the Department of Health.
(c)(1) The department shall establish and maintain a program of reviewing and following up on positive cases so that measures may be taken to prevent intellectual and other developmental disability or other permanent disabilities.
(2)(A) Information on newborn infants and their families compiled under this section may be used by the department and persons or public or private entities designated by the department.
(B) Information used under subdivision (c)(2)(A) of this section may not refer to or disclose the identity of any person.
(3) All materials, data, and information received by the department are confidential and are not subject to examination or disclosure as public information under the Freedom of Information Act of 1967, § 25-19-101 et seq.
(d)(1) The department shall conduct an intensive educational and training program among physicians, hospitals, public health nurses, and the public concerning the disorders covered under this section.
(2) The program shall include information concerning:
(A) The nature of the disorders;
(B) Testing for the detection of these disorders; and
(C) Treatment modalities for these disorders.
(e) The provisions of this section shall not apply if the parents or legal guardian of a newborn infant object to the testing on medical, religious, or philosophical grounds.
(f) Testing for cystic fibrosis under this section shall be implemented only if funding is available.
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Arkansas Code — all titles (historical 2020) · legal_authorities
25-19-101. Title.
This chapter shall be known and cited as the “Freedom of Information Act of 1967”.
Source: Arkansas Code — historical release 78 (November 6, 2020) · 25-19-101
Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. The source passage cites 25-19-101. This identifies an authority to review, not proof of applicability.